Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manulife Financial Corporation (MFC) vs Stryker Corporation (SYK) Price & Performance

Manulife Financial CorporationTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Manulife Financial Corporation vs Stryker Corporation — how do they compare? Manulife Financial Corporation trades at $43.91 (market cap $72.68B), while Stryker Corporation trades at $342.28 (market cap $133.54B). The key difference: Stryker Corporation is the larger of the two by market cap, and Manulife Financial Corporation pays the higher dividend (3.1%). Which is the better fit depends on your goals.

MFCSYK
Market Cap
$72.68B$133.54B
Sector
FinancialsTechnology
52-Week High
$44.77$394.34
52-Week Low
$30.06$282.58
Enterprise Value
$67.84B$145.01B
Dividend Yield
3.1%1.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manulife Financial Corporation

Manulife Financial (MFC) trades at $44.15, down 0.38% on the day, with a bullish technical signal from moving averages and neutral oscillators. Revenue grew to $53.01B in 2025, with net income of $5.78B, and the company has a strong analyst consensus of 57% buy ratings. Recent Q2 2026 earnings beat expectations, driven by Asia growth and insurance sales, while dividends of $0.49 per share were declared for H1 and H2 2026.

MFC's outlook is positive due to earnings momentum and strategic AI partnerships, but risks include premium valuation and segment volatility. The stock offers steady dividends and growth potential, though investors should monitor execution in wealth management and macroeconomic impacts on insurance demand.

Stryker Corporation

Stryker (SYK) trades at $341.17, down 1.34% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $379.44. The company reported strong Q2 2026 results with a 9% organic sales growth and an EPS beat, recovering from a Q1 cyber incident. Profitability remains robust with a net income margin of 14.43% and a dividend yield supported by recent increases.

The stock offers upside potential driven by earnings momentum and product innovation like Mako RPS, but risks include competitive pressures and past cybersecurity disruptions. Analyst sentiment is strongly bullish with 74% buy ratings, though valuation multiples like a P/E of 36.08 suggest premium pricing relative to historical norms.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK